|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 05, 2018 ) Geographically, orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. Presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving growth of Asia Pacific orthobiologics market.
Orthobiologics Market Research Sample Papers Available Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1198782 .
The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents.
Report studies orthobiologics market based on product, application, & enduser. Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities & challenges in market and provides details of competitive landscape for market leaders.
Orthobiologics Market, By Product
1 Introduction
2 Viscosupplementation Products
3 Demineralized Bone Matrices
4 Synthetic Orthobiologics
5 Bone Morphogenic Protein
6 Allografts
7 Plasma-Rich Protein
8 Bone Marrow Aspirate Concentrate
Orthobiologics Market, By Application
1 Introduction
2 Osteoarthritis and Degenerative Arthritis
3 Spinal Fusion
4 Soft-Tissue Injuries
5 Fracture Recovery
6 Maxillofacial and Dental Applications
Click Here For More Information on Orthobiologics Market at with Top Trends and Company Profiles at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1198782 .
The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.
Key Stakeholders
1 Orthobiologics Product Manufacturing Companies
2 Product Suppliers, Distributors, and Channel Partners
3 Hospitals and Ambulatory Care Centers
4 Orthopedic and Dental Clinics
5 Research Laboratories and CROs
6 Research and Academic Institutes
7 National and International Regulatory Authorities
8 Government and Non-government Organizations
9 Market Research Firms
Get Discount on “Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022” report at https://www.reportsnreports.com/contacts/discount.aspx?name=1198782 .
Report broadly segments the orthobiologics market into product, application, and end user. On the basis of product, the market is categorized into allografts, synthetic orthobiologics, PRP, BMAC, DBM, BMP, and viscosupplementation products. In 2017, the viscosupplementation products segment is expected to account for the largest share of the market.
The report covers the orthobiologics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017 due to the increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies.
ReportsnReports
Vishal
+ 18883915441
ganesh.pardeshi@reportsandreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
